Centerpiece12.14.20
Centerpiece, a medical device contract manufacturing and sterilization company, has announced it will be launching a new ethylene-oxide sterilization facility in Tijuana, Mexico early next year. The facility will add both high and low volume processing to a region that employs over 70,000 people dedicated to the medical device industry.
“Tijuana is the leading medical device manufacturing hub in North America and is a strategic production center for US markets. Our downstream investment into ethylene-oxide processing will streamline supply chains and provide much needed sterilization capacity for a wide array of product portfolios,” commented Matt Jordan, Centerpiece’s CEO.
The 140,000 ft2 facility is equipped with state-of-the-art processing and emissions control equipment. Its sterilization chamber configuration also leverages chamber-specific preconditioning and aeration cells, moving product throughout the process via auto-pallet transfer systems.
Additionally, Centerpiece’s sterilization offering compliments its own contract manufacturing capabilities. OEM’s looking for a total supply chain solution, rather than just a contract manufacturer, now have an end-to-end offering.
“We’ve assessed the complete ecosystem of our industry and subsequently invested accordingly,” concluded Matt Jordan.
“Tijuana is the leading medical device manufacturing hub in North America and is a strategic production center for US markets. Our downstream investment into ethylene-oxide processing will streamline supply chains and provide much needed sterilization capacity for a wide array of product portfolios,” commented Matt Jordan, Centerpiece’s CEO.
The 140,000 ft2 facility is equipped with state-of-the-art processing and emissions control equipment. Its sterilization chamber configuration also leverages chamber-specific preconditioning and aeration cells, moving product throughout the process via auto-pallet transfer systems.
Additionally, Centerpiece’s sterilization offering compliments its own contract manufacturing capabilities. OEM’s looking for a total supply chain solution, rather than just a contract manufacturer, now have an end-to-end offering.
“We’ve assessed the complete ecosystem of our industry and subsequently invested accordingly,” concluded Matt Jordan.
